Update on the Phase 4 Confirmatory Study of ADUHELM®
Go back to Update on the Phase 4 Confirmatory Study of ADUHELM®| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 208.46 -7.66 (3.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $216.12 | 52 Week High | $333.65 | |||
| Open | $215.95 | 52 Week Low | $223.02 | |||
| Day High | $215.95 | P/E | 26.69 | |||
| Day Low | $208.27 | EPS | $7.81 | |||
| Volume | 1,218,473 | |||||
